# Cluster2-72 Analysis

## Proteins: 

CCAR2, CD33, LDB2, LMX1B

### Nucleoplasmic Protein Interaction System

#### Summary

The human protein system under investigation consists of four proteins: CD33, CCAR2, LMX1B, and LDB2. These proteins are involved in various cellular processes, such as protein binding, nucleoplasm localization, nuclear localization, plasma membrane association, enzyme binding, chromatin association, and transcription by RNA polymerase II. The system is primarily located in the nucleoplasm and nucleus, with some components also found at the plasma membrane.

CD33 is a transmembrane receptor protein primarily expressed on the surface of myeloid cells, playing a role in cell adhesion and immune response modulation (1). CCAR2, also known as DBC1, is a nuclear protein involved in the regulation of various cellular processes, including DNA damage response, apoptosis, and transcriptional regulation (2). LMX1B is a transcription factor that plays a crucial role in the development of dorsal limb structures and the nervous system (3). LDB2 is a nuclear protein that functions as a transcriptional coactivator, interacting with other transcription factors to regulate gene expression (4).

The presence of protein binding among all four proteins suggests that they may form a protein complex or interact with each other in some capacity. The nucleoplasm and nucleus localization of three proteins (CD33, CCAR2, and LDB2) indicate that this system may be involved in nuclear processes, such as transcriptional regulation and chromatin remodeling. The association of two proteins (CCAR2 and LMX1B) with chromatin further supports this notion. Additionally, the involvement of LMX1B and LDB2 in transcription by RNA polymerase II highlights the potential role of this system in gene expression regulation.

Based on the cellular location and function of these proteins, we propose the name "Nucleoplasmic Protein Interaction System" for this human protein system. Further investigation is required to determine if this is a novel complex or if any proteins are novel members of a known complex.

#### References

1. Paul, S. P., Taylor, L. S., Stansbury, E. K., & McVicar, D. W. (2000). Myeloid specific human CD33 is an inhibitory receptor with differential ITIM function in recruiting the phosphatases SHP-1 and SHP-2. *Blood*, 96(2), 483-490.

2. Chini, E. N., Chini, C. C., Nin, V., & Escande, C. (2013). Deleted in breast cancer-1 (DBC-1) in the interface between metabolism, aging and cancer. *Bioscience reports*, 33(5), e00064.

3. Hobert, O., & Westphal, H. (2000). Functions of LIM-homeobox genes. *Trends in Genetics*, 16(2), 75-83.

4. Matthews, J. M., & Visvader, J. E. (2003). LIM-domain-binding protein 1: a multifunctional cofactor that interacts with diverse proteins. *EMBO reports*, 4(12), 1132-1137.

### Validated References: 

None





## Gene Feature Summary: 

| Feature | Number of Genes | Genes |
| --- | --- | --- |
| protein binding | 4 | CD33, CCAR2, LMX1B, LDB2 |
| nucleoplasm | 3 | CD33, CCAR2, LDB2 |
| nucleus | 3 | CCAR2, LMX1B, LDB2 |
| plasma membrane | 2 | CD33, LDB2 |
| enzyme binding | 2 | CCAR2, LDB2 |
| chromatin | 2 | CCAR2, LMX1B |
|  transcription by RNA polymerase II | 2 | LMX1B, LDB2 |

